310 related articles for article (PubMed ID: 16942819)
1. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
Isoda R; Simanski SP; Pathangey L; Stone AE; Brown TA
Vaccine; 2007 Jan; 25(1):117-26. PubMed ID: 16942819
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response.
Kohler JJ; Pathangey LB; Brown TA
Oral Microbiol Immunol; 1998 Apr; 13(2):81-8. PubMed ID: 9573798
[TBL] [Abstract][Full Text] [Related]
3. Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice.
Ervin SE; Small PA; Gulig PA
Microb Pathog; 1993 Aug; 15(2):93-101. PubMed ID: 8255210
[TBL] [Abstract][Full Text] [Related]
4. [Construction of hpaA gene-engineered attenuated Salmonella typhimurium vaccine strain].
Zhu S; Chen M; Chen J; Hu P; Li G
Wei Sheng Wu Xue Bao; 2002 Feb; 42(1):27-32. PubMed ID: 12557344
[TBL] [Abstract][Full Text] [Related]
5. Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.
Kohler JJ; Pathangey LB; Gillespie SR; Brown TA
Infect Immun; 2000 Jun; 68(6):3116-20. PubMed ID: 10816452
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Liu X; Hu J; Zhang X; Fan D
Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
[TBL] [Abstract][Full Text] [Related]
7. [Enhancement by an in vivo-activated promoter of immunogenicity of recombinant attenuated Salmonella typhimurium expressing hepatitis C virus core antigen].
Zhao P; Ke S; Wang HW; Qian F; Qi ZT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):266-70. PubMed ID: 12621552
[TBL] [Abstract][Full Text] [Related]
8. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
[TBL] [Abstract][Full Text] [Related]
9. Expression and delivery of tetanus toxin fragment C fused to the N-terminal domain of SipB enhances specific immune responses in mice.
Jang JI; Kim JS; Eom JS; Kim HG; Kim BH; Lim S; Bang IS; Park YK
Microbiol Immunol; 2012 Sep; 56(9):595-604. PubMed ID: 22708880
[TBL] [Abstract][Full Text] [Related]
10. Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.
Kohler JJ; Pathangey L; Hasona A; Progulske-Fox A; Brown TA
Infect Immun; 2000 Jul; 68(7):4370-3. PubMed ID: 10858264
[TBL] [Abstract][Full Text] [Related]
11. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.
Pathangey L; Kohler JJ; Isoda R; Brown TA
Vaccine; 2009 May; 27(20):2707-11. PubMed ID: 19428883
[TBL] [Abstract][Full Text] [Related]
12. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
[TBL] [Abstract][Full Text] [Related]
13. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant.
Lee SR; Kim SH; Jeong KJ; Kim KS; Kim YH; Kim SJ; Kim E; Kim JW; Chang KT
J Microbiol Biotechnol; 2009 Oct; 19(10):1271-9. PubMed ID: 19884791
[TBL] [Abstract][Full Text] [Related]
14. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
15. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
[TBL] [Abstract][Full Text] [Related]
16. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
[TBL] [Abstract][Full Text] [Related]
17. Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.
Kozarov E; Miyashita N; Burks J; Cerveny K; Brown TA; McArthur WP; Progulske-Fox A
Infect Immun; 2000 Feb; 68(2):732-9. PubMed ID: 10639440
[TBL] [Abstract][Full Text] [Related]
18. Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens.
Sizemore DR; Warner B; Lawrence J; Jones A; Killeen KP
Vaccine; 2006 May; 24(18):3793-803. PubMed ID: 16135393
[TBL] [Abstract][Full Text] [Related]
19. Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin.
Dusek DM; Progulske-Fox A; Brown TA
Infect Immun; 1994 May; 62(5):1652-7. PubMed ID: 8168925
[TBL] [Abstract][Full Text] [Related]
20. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
